Global Retirement Partners LLC Grows Stake in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Global Retirement Partners LLC lifted its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBIFree Report) by 9.1% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 2,474 shares of the exchange traded fund’s stock after purchasing an additional 206 shares during the period. Global Retirement Partners LLC’s holdings in SPDR S&P Biotech ETF were worth $220,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds have also modified their holdings of XBI. Resources Management Corp CT ADV grew its stake in SPDR S&P Biotech ETF by 1,715.8% during the 2nd quarter. Resources Management Corp CT ADV now owns 345 shares of the exchange traded fund’s stock valued at $29,000 after acquiring an additional 326 shares in the last quarter. Tyler Stone Wealth Management purchased a new stake in SPDR S&P Biotech ETF during the 2nd quarter valued at about $33,000. EPG Wealth Management LLC grew its stake in SPDR S&P Biotech ETF by 152.7% during the 3rd quarter. EPG Wealth Management LLC now owns 460 shares of the exchange traded fund’s stock valued at $34,000 after acquiring an additional 278 shares in the last quarter. Compass Wealth Management LLC purchased a new stake in SPDR S&P Biotech ETF during the 4th quarter valued at about $34,000. Finally, Fortis Capital Advisors LLC purchased a new stake in SPDR S&P Biotech ETF during the 4th quarter valued at about $38,000.

SPDR S&P Biotech ETF Trading Up 0.4 %

Shares of NYSEARCA XBI opened at $91.04 on Thursday. SPDR S&P Biotech ETF has a 12-month low of $63.80 and a 12-month high of $103.52. The stock has a market cap of $6.98 billion, a PE ratio of 11.47 and a beta of 0.97. The company has a 50-day moving average of $93.78 and a 200 day moving average of $83.09.

SPDR S&P Biotech ETF Company Profile

(Free Report)

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.

Further Reading

Institutional Ownership by Quarter for SPDR S&P Biotech ETF (NYSEARCA:XBI)

Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.